IRL-1720 is a synthetic peptide analog used to examine structure–activity relationships in receptor-mediated signaling. Its sequence supports conformational analyses that highlight residue contributions to recognition. Researchers employ it to assess ligand stability and orientation. The molecule aids optimization of synthetic bioactive frameworks.
CAT No: E09008
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More